Financials
- Market Capitalization 275.95 M
- Employee 35
- Founded 2008
- CEO N/A
- Website www.inhibikase.com
- Headquarter Delaware, United States
- FIGI BBG005TP2339
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-4.18
市销率
53.93
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 3389 | MGNX MacroGenics, Inc. - Common Stock | 4.45 USD | -1.11% | -5.12% | +12.37% | +183.44% | 282.86 M USD | ||
| 3398 | SABS SAB Biotherapeutics, Inc. - Common Stock | 3.66 USD | -1.88% | -6.63% | +6.40% | +51.24% | 279.86 M USD | ||
| 3410 | GLSI Greenwich LifeSciences, Inc. - Common stock | 18.74 USD | +0.92% | -8.14% | -23.26% | +75.30% | 275.07 M USD | ||
| 3433 | SRZN Surrozen, Inc. - Common Stock | 22.73 USD | -0.35% | -2.99% | -5.21% | +167.10% | 263.90 M USD |